Clinical Trial

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 12, 2024 (before its estimated May 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-25; most recent amendment 2025-10-21.
Status change: Recruiting → Terminated 2025-05-19
Status change: Not Yet Recruiting → Recruiting 2024-04-10
Trial Details
NCT Number NCT05309460
Lead Sponsor Nebraska Methodist Health System
Conditions Postpartum Preeclampsia, Hypertension in Pregnancy
Enrollment 600 participants
Start Date 2022-06-20
Primary Completion 2024-05-01 (estimated)
Study Completion 2024-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-12